Heart Health Archive

Omega-3 fatty acids from fish and fish oil have been recommended by the American Heart Association for the past 20 years to reduce cardiovascular events in people who already have cardiovascular disease. But the results of studies of omega-3 supplements have been mixed, leaving both doctors and patients still wondering what to do.

Research we're watching

Reliable blood pressure readings are vital for diagnosing high blood pressure and estimating a person's risk of heart disease. New research suggests that using a home blood pressure monitor may be more dependable than other methods.

Doctors have long relied on office visits to check people's blood pressure. But growing evidence shows that readings done outside a doctor's office are more closely linked to a person's risk of heart-related problems. Ambulatory blood pressure monitoring (ABPM) involves wearing a device that automatically records blood pressure every 30 to 60 minutes for 24 hours, but it's not widely available.

Research we're watching

Widely considered the healthiest diet for your heart, the Mediterranean diet is rich in plant-based foods and features only small amounts of meat and dairy products. But a variation that includes more green plant foods may be even better for you, a small study suggests.

The study included 294 sedentary, moderately obese people whom researchers randomly divided into three groups. Each received different dietary advice: a standard healthy diet, a low-calorie Mediterranean diet, or a "green" Mediterranean diet. Both Mediterranean diet groups included about a quarter-cup of walnuts daily, and poultry and fish replaced beef and lamb.

Research we're watching

People with atrial fibrillation (afib) who consume more than 14 alcoholic beverages a week may face a higher risk of stroke and other blood clot-related problems, according to a new study.

The study included 9,411 people with afib, who were divided into four groups based on how much they typically drank per week: abstainers or rare drinkers (less than one), light drinkers (less than seven), moderate (seven to 14), and heavy (14 or more). Researchers then tracked the participants for a median follow-up period of 17.4 months, noting the incidence of strokes, transient ischemic attacks (ministrokes), blood clots in a limb or organ (embolisms), or hospitalization for management of either atrial fibrillation or heart failure.

Cardiovascular problems can conspire to put a damper on sexual enjoyment. Talking to your doctor and your partner can help.

A physical connection with your romantic partner is often an important part of a fulfilling relationship. But when it comes to matters of the heart, the health of your heart matters.

"A satisfying sex life depends on physical health, psychological well-being, and the quality of the relationship," says Dr. Jan Shifren, who directs the Massachusetts General Hospital Midlife Women's Health Center. Heart disease and related conditions can influence all three of those factors in both men and women. Here's a look at the range of those effects and some possible solutions.

Ask the doctor

Q. My aunt was having heart palpitations and recently found out that she has bigeminy. According to her doctor, it's not serious. But what exactly is this condition?

A. Bigeminy refers to a heartbeat marked by two beats close together with a pause following each pair of beats. The term comes from the Latin bigeminus, meaning double or paired (bi means two, geminus means twin).

Hamburgers, fries, sugary sodas, and other less healthy foods may cause inflammation, a key player in the formation of artery-clogging plaque.

Eating foods such as red meat and sugary treats may trigger inflammation, raising your risk of cardiovascular disease. But a diet rich in fruits, vegetables, and other anti-inflammatory foods reduces the risk, according to a large Harvard study.

"These new findings help explain why certain foods we consider unhealthy may be contributing to plaque buildup inside arteries," says Dr. Kathryn Rexrode, associate professor of medicine at Harvard Medical School and a co-author of the study, published last year in the Journal of the American College of Cardiology. Inflammation is marked by the release of molecules called cytokines into the bloodstream. These attract immune cells to artery walls, contributing to the development of plaque, she explains.

A novel study suggests that the "nocebo effect" could be why some people believe they cannot tolerate statins.

Are you hesitant to fill your statin prescription because you're worried the drug will cause muscle aches and other side effects? Although you're far from alone (see "A royal pain?"), the reality is that all drugs have side effects, and statins aren't worse than other drugs. And fears about statin side effects may be depriving people of a potentially lifesaving medication.

The nocebo effect — the flip side of the well-known placebo effect — occurs when people experience negative effects from a drug, placebo, or other treatment based on an expectation of harm. Because of the widespread belief that statins cause muscle aches, statins have been suspected of triggering a strong nocebo effect. A recent study confirmed this observation (see "A study to assess statin side effects").

Treadmills and related fitness equipment can make aerobic workouts more convenient. Which type is best for you?

Even if you enjoy exercising outdoors, there are times when it's too cold, too hot, or otherwise uncomfortable or impractical to walk, jog, or cycle outside. And like many people, perhaps you've let your gym membership lapse. So how do you make sure you're getting an aerobic, heart-protecting workout most days of the week?

Maybe it's time to invest in a home exercise machine, such as a treadmill or elliptical machine. Not only can you exercise in the privacy of your home, you can also easily break up your workout into 10- to 15-minute stints throughout the day, whenever it's convenient for you. Current guidelines recommend getting at least 2.5 hours of heart rate–elevating (aerobic) exercise each week.

About one in five people has high levels of lipoprotein(a), a fatty particle linked to premature heart disease.

Most people probably haven't heard of lipoprotein(a), although that's not surprising. Cardiologists have known for years that having high levels of these fatty particles circulating in the bloodstream poses a risk to the cardiovascular system. But there wasn't much they could offer in terms of therapy, so widespread testing for lipoprotein(a) — also known as Lp(a) — didn't make sense.

Recent progress means the landscape may soon be shifting. Earlier research showed that injectable cholesterol-lowering drugs known as PCSK9 inhibitors, such as evolocumab (Repatha) or alirocumab (Praluent), may lower Lp(a) by up to 25%. Until last year, however, it wasn't clear whether that reduction actually helped people with high Lp(a).